skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Nuclear medicine and imaging research (quantitative studies in radiopharmaceutical science)

Abstract

This is a report of progress in Year Two (January 1, 1990--December 31, 1990) of Grant FG02-86ER60438, Quantitative Studies in Radiopharmaceutical Science,'' awarded for the three-year period January 1, 1989--December 31, 1991 as a competitive renewal following site visit in the fall of 1988. This program addresses the problems involving the basic science and technology underlying the physical and conceptual tools of radioactive tracer methodology as they relate to the measurement of structural and functional parameters of physiologic importance in health and disease. The principal tool is quantitative radionuclide imaging. The overall objective of this program is to further the development and transfer of radiotracer methodology from basic theory to routine clinical practice in order that individual patients and society as a whole will receive the maximum net benefit from the new knowledge gained. The focus of the research is on the development of new instruments and radiopharmaceuticals, and the evaluation of these through the phase of clinical feasibility. 25 refs., 13 figs., 1 tab.

Authors:
;
Publication Date:
Research Org.:
Franklin McLean Memorial Research Inst., Chicago, IL (USA)
Sponsoring Org.:
DOE/ER
OSTI Identifier:
6604409
Report Number(s):
DOE/ER/60438-2
ON: DE90017604
DOE Contract Number:  
FG02-86ER60438
Resource Type:
Technical Report
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; CENTRAL NERVOUS SYSTEM; POSITRON COMPUTED TOMOGRAPHY; NUCLEAR MEDICINE; RESEARCH PROGRAMS; RADIOPHARMACEUTICALS; DIAGNOSTIC USES; DOPAMINE; EPILEPSY; EXPERT SYSTEMS; FEASIBILITY STUDIES; FLUORINE 18; GLUCOSE; IMAGE PROCESSING; MATHEMATICAL MODELS; METABOLISM; NERVOUS SYSTEM DISEASES; PHYSIOLOGY; PROGRESS REPORT; RADIOCHEMISTRY; TRACER TECHNIQUES; UPTAKE; ALDEHYDES; AMINES; AROMATICS; AUTONOMIC NERVOUS SYSTEM AGENTS; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; CARBOHYDRATES; CARDIOTONICS; CARDIOVASCULAR AGENTS; CHEMISTRY; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; DOCUMENT TYPES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; FLUORINE ISOTOPES; HEXOSES; HOURS LIVING RADIOISOTOPES; HYDROXY COMPOUNDS; ISOMERIC TRANSITION ISOTOPES; ISOTOPE APPLICATIONS; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MEDICINE; MONOSACCHARIDES; NERVOUS SYSTEM; NEUROREGULATORS; NUCLEI; ODD-ODD NUCLEI; ORGANIC COMPOUNDS; PHENOLS; POLYPHENOLS; PROCESSING; RADIOISOTOPES; SACCHARIDES; SYMPATHOMIMETICS; TOMOGRAPHY; USES; 550601* - Medicine- Unsealed Radionuclides in Diagnostics

Citation Formats

Cooper, M D, and Beck, R N. Nuclear medicine and imaging research (quantitative studies in radiopharmaceutical science). United States: N. p., 1990. Web.
Cooper, M D, & Beck, R N. Nuclear medicine and imaging research (quantitative studies in radiopharmaceutical science). United States.
Cooper, M D, and Beck, R N. Sat . "Nuclear medicine and imaging research (quantitative studies in radiopharmaceutical science)". United States.
@article{osti_6604409,
title = {Nuclear medicine and imaging research (quantitative studies in radiopharmaceutical science)},
author = {Cooper, M D and Beck, R N},
abstractNote = {This is a report of progress in Year Two (January 1, 1990--December 31, 1990) of Grant FG02-86ER60438, Quantitative Studies in Radiopharmaceutical Science,'' awarded for the three-year period January 1, 1989--December 31, 1991 as a competitive renewal following site visit in the fall of 1988. This program addresses the problems involving the basic science and technology underlying the physical and conceptual tools of radioactive tracer methodology as they relate to the measurement of structural and functional parameters of physiologic importance in health and disease. The principal tool is quantitative radionuclide imaging. The overall objective of this program is to further the development and transfer of radiotracer methodology from basic theory to routine clinical practice in order that individual patients and society as a whole will receive the maximum net benefit from the new knowledge gained. The focus of the research is on the development of new instruments and radiopharmaceuticals, and the evaluation of these through the phase of clinical feasibility. 25 refs., 13 figs., 1 tab.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {1990},
month = {9}
}

Technical Report:
Other availability
Please see Document Availability for additional information on obtaining the full-text document. Library patrons may search WorldCat to identify libraries that may hold this item. Keep in mind that many technical reports are not cataloged in WorldCat.

Save / Share: